6 completed, 4 unknown, 1 active not recruiting, 1 terminated. 4 Phase 3, 4 Phase 4, 3 Phase 2, 2 Not applicable, 1 Phase 1.
Follow Lumigan: new trials by email Literature Review of Lumigan trials Research Report on Lumigan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma Netarsudil Ophthalmic, Bimatoprost Ophthalmic - Normal Tension Glaucoma | Phase 4 | Unknown | Salus University | 115 | 2021-08-01 | 2021-08-06 |
| AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension AGN-193408 SR, Lumigan, Sham Administration - Open-angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | Active not recruiting | AbbVie | 100 | 2020-11-16 | 2026-05-22 |
| A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension Bimatoprost SR, LUMIGAN - Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | AbbVie | 37 | 2020-06-11 | 2023-06-08 |
| A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension SDP-133, Lumigan - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Sun Pharmaceutical Industries Limited | 2019-06-10 | 2021-11-19 | |
| Topical Bimatoprost in the Treatment of Migraine Bimatoprost Topical Solution, Control - Migraine Disorders, Headache Disorders | Phase 2 | Unknown | Manistee Partners | 70 | 2018-01-05 | 2019-04-26 |
| Stop Retinal Ganglion Cell Dysfunction Study Latanoprost, Bimatoprost, Travoprost - Glaucoma | Phase 3 | Terminated | University of Miami | 28 | 2015-09-01 | 2025-08-26 |
| A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension Fixed-Combination Bimatoprost/Brimonidine, Bimatoprost Ophthalmic Solution 0.01%, Vehicle Ophthalmic Solution - Glaucoma, Ocular Hypertension | Phase 2 | Completed | Allergan | 112 | 2013-06-01 | 2015-01-26 |
| Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves Aqueous Suppressant Eye Drops - Glaucoma | Phase 4 | Unknown | Credit Valley EyeCare | 150 | 2012-02-01 | 2017-07-21 |
| Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination Bimatoprost and Bimatoprost/Timolol fixed combination. - Glaucoma, Ocular Hypertension | Phase 4 | Completed | Larissa University Hospital | 30 | 2009-07-01 | 2010-11-30 |
| Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma Latanoprost, bimatoprost, travoprost, travoprost, latanoprost and bimatoprost - Ocular Hypertension, Primary Glaucoma | Not applicable | Unknown | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 141 | 2009-01-01 | 2011-05-27 |
| Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes Bimatoprost Suspension - Hypertrichosis | Not applicable | Completed | University of Miami | 21 | 2008-02-01 | 2014-04-16 |
| Study of Bimatoprost Gel on Eyelash Growth Bimatoprost eyelash gel - Madarosis, Hypotrichosis | Phase 3 | Completed | Duke University | 20 | 2007-02-01 | 2014-07-16 |
| Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic solution, Bimatoprost .03% sterile ophthalmic solution - Glaucoma, Ocular Hypertension | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 375 | 2002-01-01 | 2021-02-02 |
Ocular Hypertension (8) · Glaucoma (6) · Glaucoma, Open-Angle (3) · Headache (1) · Headache Disorders (1) · Hypertrichosis (1) · Hypotrichosis (1) · Low Tension Glaucoma (1) · Migraine Disorders (1)
AbbVie (2) · University of Miami (2) · Allergan (1) · Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1) · Credit Valley EyeCare (1) · Duke University (1) · Larissa University Hospital (1) · Manistee Partners (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Salus University (1) · Sun Pharmaceutical Industries Limited (1)
United States (9) · Canada (2) · Greece (1) · Japan (1)
Amandeep S Rai, MD (1) · Devesh K Varma, MD FRCSC (1) · Ike K Ahmed, MD FRCSC (1) · Jingyun Wang, Ph.D (1) · Pierre Blondeau, MD (1) · Robert L Bratzler, PhD (1) · Vittorio Porciattti, DSc (1) · Wendy W Lee, MD (1)
R01EY014957 (1)